Gene · 6646
Papers1,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Generation and characterization of human induced pluripotent stem cells from neuropathologically confirmed multiple system atrophy patient-derived fibroblasts. | Front Immunol | 2026 | 41808829 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| Alterations in lipid metabolism and blood profile in gynecological cancers - potential strategies in diagnosis and treatment. | Front Physiol | 2026 | 41778199 | PubTator, text mining | PubMed |
| Brain lipidomics for region-specific biomarker discovery in neurodegenerative diseases. | Front Aging Neurosci | 2026 | 41757360 | PubTator, text mining | PubMed |
| The Potential of Non-Ribosomal Peptide Engineering for Creating New Antimicrobial Complexes. | Molecules | 2026 | 41752460 | PubTator, text mining | PubMed |
| Metabolic Messengers: Extracellular Vesicles as Central Mediators of Metabolic Reprogramming in Renal Cell Cancer. | Biomedicines | 2026 | 41751181 | PubTator, text mining | PubMed |
| Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. | Biomolecules | 2026 | 41750397 | PubTator, text mining | PubMed |
| NLRP3 inflammasome as a therapeutic target in oral squamous cell carcinoma: implications for tumorigenesis and immunomodulation. | Int Immunopharmacol | 2026 | 41747600 | PubTator, text mining | PubMed |
| Two δ-catenins, plakophilin 4 and p120, promote formation of distinct types of adherens junctions. | J Cell Biol | 2026 | 41746206 | PubTator, text mining | PubMed |
| Lipoprotein Metabolism in Hematological Malignancies: A Role in Shaping the Tumor Cell Microenvironment? | Metabolites | 2026 | 41745626 | PubTator, text mining | PubMed |
| Tree species diversity promotes soil microbial carbon fixation gene abundance via nutrient-mediated interactions in subtropical forests. | Front Microbiol | 2026 | 41743140 | PubTator, text mining | PubMed |
| Prevalence of chromosomal abnormalities and polymorphisms in 4,672 infertile patients undergoing assisted reproductive techniques in the United Arab Emirates population. | Front Reprod Health | 2026 | 41727870 | PubTator, text mining | PubMed |
| The impact of p53 mutation on tumor immune evasion: mechanistic insights and clinical implications. | Front Immunol | 2026 | 41727427 | PubTator, text mining | PubMed |
| Zika virus and host protein interactions for understanding molecular mechanisms of pathogenesis and therapeutic development. | Front Cell Infect Microbiol | 2026 | 41716461 | PubTator, text mining | PubMed |
| Metabolic hubs in reproduction: The regulatory network of lipid droplets in gamete and embryo physiology (Review). | Int J Mol Med | 2026 | 41716021 | PubTator, text mining | PubMed |
| Lipids in kidney diseases: from systemic imbalance to intrarenal alterations of cellular lipid metabolism in rare and common kidney diseases. | J Mol Med (Berl) | 2026 | 41714434 | PubTator, text mining | PubMed |
| m6A demethylase-driven reprogramming of leukemia-associated macrophages predicts improved outcomes in acute myeloid leukemia. | Front Immunol | 2026 | 41710900 | PubTator, text mining | PubMed |
| STAT1 signaling controls cholesterol metabolism in epithelial cells and RSV-induced syncytia formation. | Npj Viruses | 2026 | 41699197 | PubTator, text mining | PubMed |
| Targeting Pathways Implicated in Cholesterol Metabolism for Novel Cancer Therapy. | Cancers (Basel) | 2026 | 41681900 | PubTator, text mining | PubMed |
| Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression. | J Cell Mol Med | 2026 | 41652992 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6646/papers?page=2